Published in Exp Gerontol on January 15, 2014
Aging of the T cell compartment in mice and humans: from no naive expectations to foggy memories. J Immunol (2014) 1.31
HIV infection Worsens Age-Associated Defects in Antibody Responses to Influenza Vaccine. J Infect Dis (2015) 0.84
Expression of CD39 on Activated T Cells Impairs their Survival in Older Individuals. Cell Rep (2016) 0.84
Recent thymic emigrants are tolerized in the absence of inflammation. J Exp Med (2016) 0.84
Hantaan virus infection induces both Th1 and ThGranzyme B+ cell immune responses that associated with viral control and clinical outcome in humans. PLoS Pathog (2015) 0.82
Innate immune responses in the ageing lung. Clin Exp Immunol (2016) 0.82
T-Cell Immunity to Influenza in Older Adults: A Pathophysiological Framework for Development of More Effective Vaccines. Front Immunol (2016) 0.81
Age-Associated Failure To Adjust Type I IFN Receptor Signaling Thresholds after T Cell Activation. J Immunol (2015) 0.79
New Insights into the Generation of CD4 Memory May Shape Future Vaccine Strategies for Influenza. Front Immunol (2016) 0.78
Age-related changes in the transcriptome of antibody-secreting cells. Oncotarget (2016) 0.77
IL-6 Production by TLR-Activated APC Broadly Enhances Aged Cognate CD4 Helper and B Cell Antibody Responses In Vivo. J Immunol (2017) 0.75
The effects of age and cytomegalovirus on markers of inflammation and lymphocyte populations in captive baboons. PLoS One (2014) 0.75
IL-2 and IL-6 cooperate to enhance the generation of influenza-specific CD8 T cells responding to live influenza virus in aged mice and humans. Oncotarget (2016) 0.75
Mechanisms Underlying T Cell Immunosenescence: Aging and Cytomegalovirus Infection. Front Microbiol (2016) 0.75
Cytotoxic CD4 T Cells-Friend or Foe during Viral Infection? Front Immunol (2017) 0.75
Race-related differences in antibody responses to the inactivated influenza vaccine are linked to distinct pre-vaccination gene expression profiles in blood. Oncotarget (2016) 0.75
Aging increases cell-to-cell transcriptional variability upon immune stimulation. Science (2017) 0.75
Dendritic-cell immunotherapy: from ex vivo loading to in vivo targeting. Nat Rev Immunol (2007) 3.42
Age-associated decline in T cell repertoire diversity leads to holes in the repertoire and impaired immunity to influenza virus. J Exp Med (2008) 3.15
Normal T cell homeostasis: the conversion of naive cells into memory-phenotype cells. Nat Immunol (2011) 2.81
Interleukin 2, but not other common gamma chain-binding cytokines, can reverse the defect in generation of CD4 effector T cells from naive T cells of aged mice. J Exp Med (1999) 2.33
Biology of immune responses to vaccines in elderly persons. Clin Infect Dis (2008) 2.32
Age-related defects in CD4 T cell cognate helper function lead to reductions in humoral responses. J Exp Med (2004) 2.23
Transcriptional reprogramming of mature CD4⁺ helper T cells generates distinct MHC class II-restricted cytotoxic T lymphocytes. Nat Immunol (2013) 2.11
Understanding immunosenescence to improve responses to vaccines. Nat Immunol (2013) 2.09
Mechanism of action of clinically approved adjuvants. Curr Opin Immunol (2009) 2.06
Vaccination against tetanus in the elderly: do recommended vaccination strategies give sufficient protection. Lancet (1996) 2.05
Inflammatory cytokines overcome age-related defects in CD4 T cell responses in vivo. J Immunol (2004) 1.83
MF59-adjuvanted vaccines: increased immunogenicity with an optimal safety profile. Expert Rev Vaccines (2003) 1.64
A dendritic cell-based vaccine elicits T cell responses associated with control of HIV-1 replication. Sci Transl Med (2013) 1.62
Multifunctional CD4 cells expressing gamma interferon and perforin mediate protection against lethal influenza virus infection. J Virol (2012) 1.61
Genes involved in immune response/inflammation, IGF1/insulin pathway and response to oxidative stress play a major role in the genetics of human longevity: the lesson of centenarians. Mech Ageing Dev (2005) 1.49
Cytotoxic CD4 T cells in antiviral immunity. J Biomed Biotechnol (2011) 1.49
The effect of age on the B-cell repertoire. J Clin Immunol (2000) 1.47
B cells and aging: molecules and mechanisms. Trends Immunol (2009) 1.38
The involvement of the intestinal microflora in the expansion of CD4+ T cells with a naive phenotype in the periphery. Dev Immunol (1992) 1.34
Age-associated increase in lifespan of naive CD4 T cells contributes to T-cell homeostasis but facilitates development of functional defects. Proc Natl Acad Sci U S A (2009) 1.34
Effect of age on humoral immunity, selection of the B-cell repertoire and B-cell development. Immunol Rev (1997) 1.32
Mechanisms for decreased function of B cells in aged mice and humans. J Immunol (2008) 1.31
Proinflammatory adjuvants enhance the cognate helper activity of aged CD4 T cells. J Immunol (2009) 1.20
Memory CD4+ T-cell-mediated protection depends on secondary effectors that are distinct from and superior to primary effectors. Proc Natl Acad Sci U S A (2012) 1.10
Comparison of the safety, tolerability, and immunogenicity of a MF59-adjuvanted influenza vaccine and a non-adjuvanted influenza vaccine in non-elderly adults. Vaccine (2003) 1.08
The B-cell biology of aging. Immunol Rev (1997) 1.07
Advancing age leads to predominance of inhibitory receptor expressing CD4 T cells. Mech Ageing Dev (2009) 1.06
Targeting dendritic cells--why bother? Blood (2013) 1.04
Immunological adjuvants: desirable properties and side-effects. Mol Immunol (1991) 1.03
TLR-activated dendritic cells enhance the response of aged naive CD4 T cells via an IL-6-dependent mechanism. J Immunol (2010) 1.00
Bim dictates naive CD4 T cell lifespan and the development of age-associated functional defects. J Immunol (2010) 0.98
Dendritic cell based vaccines for HIV infection: the way ahead. Hum Vaccin Immunother (2013) 0.95
Age-related defects in the cytoskeleton signaling pathways of CD4 T cells. Ageing Res Rev (2009) 0.92
The endogenous adjuvant squalene can induce a chronic T-cell-mediated arthritis in rats. Am J Pathol (2000) 0.88
Adjuvants and their signaling pathways: beyond TLRs. Nat Immunol (2003) 0.85
The aging immune system: challenges for the 21st century. Semin Immunol (2012) 0.82